Significant variation exists across countries when it comes to accessing biologic therapies for patients with FMF.

A long-term study reveals that lifestyle interventions can significantly reduce the burden of multimorbidity among adults with prediabetes.

Given the shortcomings of proteinuria alone for lupus nephritis prognosis, a team is evaluating the Treatment Response Measure for SLE (TRM-SLE), a novel multi-domain clinical outcome assessment tool.

Psychologic distress and functional impairment differ by sexual and gender minority status in pediatric patients with chronic pain.

Risankizumab was associated with sustained complete clearance of psoriasis and showed a favorable safety profile.

Study data show a continual decline in national blood lead levels among young US children, though local disparities persist.

Treatment with GAE with rapidly resorbable gelatin-based microspheres may be an effective option for knee pain in osteoarthritis.

Use of triple therapy for all patients with lupus nephritis may represent overtreatment, warranting a risk stratified approach.

Clinically significant ES among patients with SSc appear to be decreasing over time, occurring later in the disease course, and show no impact on overall survival.

Prescription NSAID exposure is not linked to a clinically meaningful increase in overall IBD-related hospitalization, though outcomes differ by disease subtype.

Higher EFV was found among patients with SpA vs RA and was associated with elevated atherosclerotic and inflammatory markers.

The FDA has expanded the clearance of an OTC glucose monitor to include children aged 2 years and older who do not use insulin.